Referred leg pain originating from the sacroiliac joint: 6-month outcomes from the prospective randomized controlled iMIA trial
Authors:
- the iMIA study groupTGthe iMIA study group
- Julius DenglerJDJulius Dengler
- Bengt SturessonBSBengt Sturesson
- Djaya KoolsDKDjaya Kools
- Daniel CherDCDaniel Cher
- Peter VajkoczyPeter Vajkoczy
- 15 September 2016
- journal article
- research article
- Published by Springer Nature in Acta Neurochirurgica
- Vol. 158 (11) , 2219-2224
Abstract
Background The first results from the randomized, controlled iFuse Implant System Minimally Invasive Arthrodesis (iMIA) trial showed that minimally invasive surgical management (MISM) of low back pain originating from the sacroiliac joint (SIJ) by placing transarticular triangular titanium implants reduced pain more effectively than conservative management (CM). We now conducted a separate analysis of the iMIA data to assess whether the referred leg pain (RLP) component of SIJ-associated pain may also be affected by MISM or CM. Methods Data from 101 patients, recruited between June 2013 and May 2015 at nine European spine care centers, were included. Forty-nine patients were randomized to CM and 51 patients to MISM. RLP was defined as pain below the gluteal fold and assessed using the visual analogue scale (VAS). Changes in RLP over 6 months were the primary endpoint. Results The prevalence of clinically significant RLP was 76.2 %. Over 6 months of follow-up, CM produced no significant change in RLP, which was 51.0 VAS points (interquartile range (IQR) 17.0–75.0) at baseline. In contrast, in the MISM cohort, we found a significant decrease in RLP from VAS 58.0 (IQR 24.5–80.0) at baseline to VAS 13.5 (IQR 0.0–39.3) after 6 months (p < 0.01). Improvement of RLP was associated only with the type of treatment (OR 5.04, p < 0.01), but not with patient age, sex, or different patterns of pain referral. Conclusions Our analysis shows that RLP is a frequent phenomenon in patients with SIJ-associated pain. At 6 months of follow-up, MISM helped relieve RLP more effectively than CM. Clinical Trial Registration-URL: http://www.clinicaltrials.gov. Unique identifier: NCT01741025.Keywords
Funding Information
- Si-Bone, Inc. (San Jose, CA, USA) (funded the trial for all authors)
This publication has 19 references indexed in Scilit:
- Six-month outcomes from a randomized controlled trial of minimally invasive SI joint fusion with triangular titanium implants vs conservative managementEuropean Spine Journal, 2016
- Randomized Controlled Trial of Minimally Invasive Sacroiliac Joint Fusion Using Triangular Titanium Implants vs Nonsurgical Management for Sacroiliac Joint DysfunctionNeurosurgery, 2015
- Referred pain location depends on the affected section of the sacroiliac jointEuropean Spine Journal, 2014
- On the definitions and physiology of back pain, referred pain, and radicular painPain, 2009
- How Often Is Low Back Pain Not Coming From the Back?Spine, 2009
- European guidelines for the diagnosis and treatment of pelvic girdle painEuropean Spine Journal, 2008
- Intensity mapping of pain referral areas in sacroiliac joint pain patientsJournal of Manipulative and Physiological Therapeutics, 2006
- Sacroiliac joint pain referral zonesArchives of Physical Medicine and Rehabilitation, 2000
- The Sacroiliac Joint in Chronic Low Back PainSpine, 1995
- Sacroiliac JointSpine, 1994